Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (128)
- Compliance and enforcement (33)
- Import and export (32)
- Shortages and supply disruptions (17)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Weight loss products (5)
- Labelling and packaging (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1296 result(s) found, displaying 1201 to 1225
-
Safety alertsThe Therapeutic Goods Administration (TGA) continues to alert prescribing doctors, dentists, pharmacists and consumers to the uncommon but important association of the use of bisphosphonate drugs with osteonecrosis of the jaw.
-
Market actions
-
Market actions
-
Market actions
-
Market actionsMicrobial contamination of the antiseptic wipes contained in the first aid kits.
-
Market actions
-
Market actions
-
-
Market actions
-
Market actionsThe company is taking this action as a precaution because of reports of a rare, but serious, eye infection, Acanthamoeba keratitis, caused by a parasite.
-
Market actions
-
Market actions
-
Market actions
-
Market actionsManufacture of the goods has been carried out by a manufacturer while the manufacturer did not hold a current licence, and the goods have been supplied whilst not complying with the applicable standards such as including labelling.
-
Market actionsA connector component used in a previous version of Fisher and Paykel CPAP masks may fail prematurely.
-
Market actionsSpecific lots are being recalled because of production-line problems at AMO's manufacturing plant, which could affect the sterility of the product.
-
Market actionsThe design of the electrical power inlet to the humidifier is faulty.
-
Market actionsPotential that the power pack could shut down the D-TRONplus Insulin Pump without any warning resulting in under-delivery of insulin.
-
Market actionsIncreasing evidence suggesting an association between the product formulation and a rare eye infection (Fusarium keratitis).
-
Safety alertsPhenylpropanolamine is no longer available in Australia due to safety concerns, including the risk of haemorrhagic stroke. Consult your doctor if you have concerns.
-
Market actionsThe products may be contaminated with bacteria and may pose a risk to health.
-
Market actionsThese products may be contaminated with bacteria and may pose a risk to health.
-
Market actions
-
Market actions
-
Safety alertsParoxetine use in early pregnancy may increase the risk of congenital malformations, particularly heart defects, so women planning to become pregnant or in early pregnancy should consult their doctor.